Novo Integrated Sciences Stock Performance
| NVOS Stock | USD 0 0.00 0.00% |
Novo Integrated holds a performance score of 13 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.23, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novo Integrated will likely underperform. Use Novo Integrated Sciences sortino ratio, semi variance, as well as the relationship between the Semi Variance and day typical price , to analyze future returns on Novo Integrated Sciences.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Novo Integrated Sciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Novo Integrated unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:10 | Dividend Date 2021-02-01 | Last Split Date 2023-11-07 |
1 | Disposition of 100 shares by Rouse Michael of Novo Integrated at 1.78 subject to Rule 16b-3 | 11/19/2025 |
2 | Acquisition by Ali Sarfaraz of 480 shares of Novo Integrated subject to Rule 16b-3 | 11/27/2025 |
3 | Acquisition by Christopher David of 2000000 shares of Novo Integrated at 0.132 subject to Rule 16b-3 | 12/05/2025 |
4 | Disposition of 5000 shares by Alpha Engines, Corp. of Novo Integrated at 1.406 subject to Rule 16b-3 | 01/16/2026 |
| Begin Period Cash Flow | 2.2 M | |
| Total Cashflows From Investing Activities | -49.2 K |
Novo Integrated Relative Risk vs. Return Landscape
If you would invest 0.50 in Novo Integrated Sciences on October 30, 2025 and sell it today you would lose (0.19) from holding Novo Integrated Sciences or give up 38.0% of portfolio value over 90 days. Novo Integrated Sciences is currently generating 22.2777% in daily expected returns and assumes 129.1883% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Novo, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Novo Integrated Target Price Odds to finish over Current Price
The tendency of Novo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 55.15 |
Based on a normal probability distribution, the odds of Novo Integrated to move above the current price in 90 days from now is about 55.15 (This Novo Integrated Sciences probability density function shows the probability of Novo Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.23 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Novo Integrated will likely underperform. In addition to that Novo Integrated Sciences has an alpha of 20.58, implying that it can generate a 20.58 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Novo Integrated Price Density |
| Price |
Predictive Modules for Novo Integrated
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novo Integrated Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Novo Integrated Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Novo Integrated is not an exception. The market had few large corrections towards the Novo Integrated's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Novo Integrated Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Novo Integrated within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 20.58 | |
β | Beta against Dow Jones | 1.23 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.16 |
Novo Integrated Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Novo Integrated for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Novo Integrated Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Novo Integrated is way too risky over 90 days horizon | |
| Novo Integrated has some characteristics of a very speculative penny stock | |
| Novo Integrated appears to be risky and price may revert if volatility continues | |
| Novo Integrated has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 13.29 M. Net Loss for the year was (13.27 M) with profit before overhead, payroll, taxes, and interest of 5.74 M. | |
| Novo Integrated Sciences currently holds about 12.68 M in cash with (2.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Disposition of 5000 shares by Alpha Engines, Corp. of Novo Integrated at 1.406 subject to Rule 16b-3 |
Novo Integrated Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Novo Stock often depends not only on the future outlook of the current and potential Novo Integrated's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novo Integrated's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18 M | |
| Cash And Short Term Investments | 844.6 K |
Novo Integrated Fundamentals Growth
Novo Stock prices reflect investors' perceptions of the future prospects and financial health of Novo Integrated, and Novo Integrated fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novo Stock performance.
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.22) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 3.02 M | ||||
| Shares Outstanding | 19.73 M | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 13.29 M | ||||
| Gross Profit | 5.74 M | ||||
| EBITDA | (10.08 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.71 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.78 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Earnings Per Share | (1.33) X | ||||
| Market Capitalization | 61.16 K | ||||
| Total Asset | 32.14 M | ||||
| Retained Earnings | (83.2 M) | ||||
| Working Capital | (3.52 M) | ||||
About Novo Integrated Performance
Assessing Novo Integrated's fundamental ratios provides investors with valuable insights into Novo Integrated's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Novo Integrated is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (55.27) | (52.50) | |
| Return On Tangible Assets | (2.65) | (2.78) | |
| Return On Capital Employed | (3.78) | (3.59) | |
| Return On Assets | (2.13) | (2.23) | |
| Return On Equity | (3.78) | (3.97) |
Things to note about Novo Integrated Sciences performance evaluation
Checking the ongoing alerts about Novo Integrated for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Novo Integrated Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Novo Integrated is way too risky over 90 days horizon | |
| Novo Integrated has some characteristics of a very speculative penny stock | |
| Novo Integrated appears to be risky and price may revert if volatility continues | |
| Novo Integrated has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 13.29 M. Net Loss for the year was (13.27 M) with profit before overhead, payroll, taxes, and interest of 5.74 M. | |
| Novo Integrated Sciences currently holds about 12.68 M in cash with (2.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Disposition of 5000 shares by Alpha Engines, Corp. of Novo Integrated at 1.406 subject to Rule 16b-3 |
- Analyzing Novo Integrated's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novo Integrated's stock is overvalued or undervalued compared to its peers.
- Examining Novo Integrated's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Novo Integrated's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novo Integrated's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Novo Integrated's stock. These opinions can provide insight into Novo Integrated's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.